Skip to content

Clinical trials

Observational Hypertension, Pulmonary trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Observational Country / region: France Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20111
20131
20142
20151
20181
20191
20212
20222
20231
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting3
Enrolling by invitation2
Not yet recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris5
Poitiers University Hospital4
Bayer2
Central Hospital, Nancy, France2
Air Liquide Santé International1
Association for Pediatric Pulmonary Hypertension1
Centre Hospitalier Universitaire de Saint Etienne1
GlaxoSmithKline1
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires1
Hospices Civils de Lyon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary23
Pulmonary Arterial Hypertension4
Heart Failure2
Pulmonary Disease, Chronic Obstructive2
Rare Diseases2
Acute Coronary Syndrome1
Anemia, Sickle Cell1
Anxiety Disorders1
Arrhythmias, Cardiac1
Cardiotoxicity1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.